VALORANT player profile · Europe region · Account level 341 · Title “Cursed” · 0 profile views
Current rank: ASCENDANT 1 - 21 RR (as of last recorded competitive match, 2026-06-15).
Peak recorded rank: ASCENDANT 2 - 43 RR (reached 2026-05-26).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 129 |
|---|---|
| Win rate | 46.7% (7 W / 8 L over 15 matches with recorded stats) |
| K/D | 0.98 (203 kills / 208 deaths / 71 assists) |
| Average combat score | 219 |
| Headshot rate | 28.1% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-10-23 | Competitive | Sunset | Skye | W | 12/14/1 | 159 | - |
| 2026-10-07 | Competitive | Sunset | Clove | L | 6/17/3 | 131 | - |
| 2026-09-27 | Competitive | Abyss | Clove | W | 8/10/5 | 140 | - |
| 2026-09-26 | Competitive | Summit | Clove | W | 17/19/12 | 235 | - |
| 2026-09-26 | Competitive | Lotus | Clove | W | 20/16/7 | 250 | - |
| 2026-09-23 | Competitive | Haven | Clove | L | 14/15/3 | 233 | - |
| 2026-06-24 | Swiftplay | Bind | Jett | L | 8/6/1 | 305 | - |
| 2026-06-15 | Competitive | Ascent | - | - | - | - | -18 |
| 2026-06-15 | Competitive | Pearl | - | - | - | - | +20 |
| 2026-06-15 | Competitive | Pearl | - | - | - | - | +19 |
| 2026-06-15 | Competitive | Fracture | - | - | - | - | -21 |
| 2026-06-14 | Competitive | Ascent | Cypher | L | 11/15/10 | 205 | -18 |
| 2026-06-14 | Competitive | Lotus | - | - | - | - | -18 |
| 2026-06-14 | Competitive | Haven | Clove | L | 13/20/8 | 150 | -18 |
| 2026-06-13 | Competitive | Breeze | - | - | - | - | -18 |
| 2026-06-13 | Competitive | Lotus | - | - | - | - | +19 |
| 2026-06-13 | Competitive | Haven | Clove | L | 17/20/9 | 226 | -17 |
| 2026-06-12 | Competitive | Fracture | - | - | - | - | +18 |
| 2026-06-12 | Competitive | Breeze | - | - | - | - | -20 |
| 2026-06-12 | Competitive | Split | - | - | - | - | -20 |
Showing 20 of 129 tracked matches. The interactive profile lists all of them.
No penalty records for this player.